Literature DB >> 8306486

Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling?

W W de Herder1, P Uitterlinden, H Pieterman, H L Tanghe, D J Kwekkeboom, H A Pols, R Singh, J H van de Berge, S W Lamberts.   

Abstract

OBJECTIVE: We wished to analyse the relative value and diagnostic accuracy of bilateral simultaneous inferior petrosal sinus blood sampling for plasma ACTH measurements when compared with pituitary magnetic resonance imaging (MRI) for the preoperative localization of microadenoma (tumour diameter < 10 mm) within the pituitary fossa in patients with Cushing's disease.
DESIGN: Pituitary MRIs were assessed blind and independently. The sinus blood sampling was performed before and after administration of corticotrophin releasing hormone (CRH). The ratios of the ACTH concentrations in plasma samples from the inferior petrosal sinuses to the concentrations in peripheral blood plasma samples (the IPS:P ratio) and the ratios of the ACTH concentrations in samples from both inferior petrosal sinuses (the intersinus gradient) were calculated. PATIENTS: Twenty consecutive patients with Cushing's disease were prospectively studied. All but two patients subsequently underwent transsphenoidal exploration of the pituitary fossa.
RESULTS: In three of 20 patients (15%), positioning of catheter tips in both inferior petrosal sinuses was unsuccessful. The diagnosis of Cushing's disease was confirmed by the greater basal IPS:P ratio amounting to > or = 2.0 in 13 of 17 patients (76%), and amounting to > or = 3.0 in CRH-stimulated peak samples in 15 of 17 patients (88%). Anatomical variations of the inferior petrosal sinus, precluding reliable conclusions about lateralization of pituitary venous ACTH drainage, were observed in five of 20 patients (25%). Adding the three patients with technical failure and one patient who presented with a macroadenoma (tumour diameter 11 mm), this left interpretable data with regard to lateralization of the microadenomas in only 11 of 20 patients (55%). In 15 of 20 patients (75%) a pituitary microadenoma was found at MRI. In 14 of these 15 patients (93%) a tumour was indeed found at that position at subsequent transsphenoidal operation. Concordance between the lateralization by the intersinus gradient and microadenoma localization by MRI was observed in six of 11 cases (55%) when using basal samples and in seven of 11 cases (64%) when using peak samples obtained after stimulation with CRH. Concordance between the lateralization by the intersinus gradient and subsequent microadenoma localization at surgery was observed in seven of 11 patients (64%) before and in eight of 11 cases (73%) after CRH stimulation. Reversal of the intersinus gradient after CRH stimulation, suggesting a shift in the lateralization to the contralateral side of the gland, was found in three of 12 cases (25%).
CONCLUSIONS: Bilateral simultaneous inferior petrosal sinus blood sampling for plasma ACTH measurements before and after CRH stimulation successfully confirmed the diagnosis of pituitary dependent Cushing's disease in 15 of 17 patients (88%) in whom this diagnosis was suspected on the basis of conventional biochemical testing. Magnetic resonance imaging, however, is superior to bilateral simultaneous inferior petrosal sinus blood sampling for the localization/lateralization of pituitary microadenomas in patients with Cushing's disease. Therefore, bilateral simultaneous inferior petrosal sinus blood sampling should be reserved for the assessment of those patients with Cushing's syndrome in whom either the results of biochemical tests are equivocal and/or subsequent pituitary magnetic resonance imaging gives unconvincing results.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306486     DOI: 10.1111/j.1365-2265.1994.tb02448.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Pituitary magnetic resonance imaging in Cushing's disease.

Authors:  Giovanni Vitale; Fabio Tortora; Roberto Baldelli; Francesco Cocchiara; Rosa Maria Paragliola; Emilia Sbardella; Chiara Simeoli; Ferdinando Caranci; Rosario Pivonello; Annamaria Colao
Journal:  Endocrine       Date:  2016-07-19       Impact factor: 3.633

2.  Intraoperative multiple-staged resection and tumor tissue identification using frozen sections provide the best result for the accurate localization and complete resection of tumors in Cushing's disease.

Authors:  Jung Soo Lim; Seung Ku Lee; Se Hoon Kim; Eun Jig Lee; Sun Ho Kim
Journal:  Endocrine       Date:  2011-06-19       Impact factor: 3.633

3.  Cushing's Disease: Pituitary Surgery versus Adrenalectomy.

Authors:  Omayma El-Shafie; Fatma B Abid; Nayal Al-Kindy; Dilip Sankhla; Nicholas J Woodhouse
Journal:  Sultan Qaboos Univ Med J       Date:  2008-07

Review 4.  Six cases of ectopic ACTH syndrome caused by thymic carcinoid.

Authors:  W Q Wang; L Ye; Y F Bi; H Y Zhao; S Y Sun; Z Y Tang; Y J Zhao; W Q Fang; Z Y Chen; K M Chen; X L Jin; G Ning
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

5.  Ultrasound in pituitary tumor surgery.

Authors:  Z Ram; B Bruck; M Hadani
Journal:  Pituitary       Date:  1999-08       Impact factor: 4.107

6.  Cost-effectiveness and accuracy of the tests used in the differential diagnosis of Cushing's syndrome.

Authors:  J Puig; A Wägner; A Caballero; J Rodríguez-Espinosa; S M Webb
Journal:  Pituitary       Date:  1999       Impact factor: 4.107

7.  CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease.

Authors:  Jacqueline Boyle; Nicholas J Patronas; James Smirniotopoulos; Peter Herscovitch; William Dieckman; Corina Millo; Dragan Maric; Grégoire P Chatain; Christina Piper Hayes; Sarah Benzo; Gretchen Scott; Nancy Edwards; Abhik Ray Chaudhury; Maya B Lodish; Susmeeta Sharma; Lynnette K Nieman; Constantine A Stratakis; Russell R Lonser; Prashant Chittiboina
Journal:  Endocrine       Date:  2019-05-06       Impact factor: 3.633

8.  Potential utility of FLAIR in MRI-negative Cushing's disease.

Authors:  Grégoire P Chatain; Nicholas Patronas; James G Smirniotopoulos; Martin Piazza; Sarah Benzo; Abhik Ray-Chaudhury; Susmeeta Sharma; Maya Lodish; Lynnette Nieman; Constantine A Stratakis; Prashant Chittiboina
Journal:  J Neurosurg       Date:  2017-10-13       Impact factor: 5.115

Review 9.  Bilateral inferior petrosal sinus sampling.

Authors:  Benedetta Zampetti; Erika Grossrubatscher; Paolo Dalino Ciaramella; Edoardo Boccardi; Paola Loli
Journal:  Endocr Connect       Date:  2016-06-27       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.